Search Results

You are looking at 141 - 150 of 201 items for :

  • "lymph node dissection" x
  • Refine by Access: All x
Clear All
Full access

Daphne Y. Lichtensztajn, John T. Leppert, James D. Brooks, Sumit A. Shah, Weiva Sieh, Benjamin I. Chung, Scarlett L. Gomez, and Iona Cheng

therapy (ADT), RT with brachytherapy with or without 2 to 3 years of ADT, or radical prostatectomy with pelvic lymph node dissection as initial treatment of all high-risk localized PCa, barring contraindications. 2 Despite these recommendations

Full access

David D. Buethe and Julio Pow-Sang

RP and pelvic lymph node dissection. Other reports confirm this observation. 17 , 23 , 28 Inspection of whole-mount prostatectomy specimens has previously shown a significant indirect correlation between percent-free PSA and prostate cancer volume

Full access

Yvonne H. Sada, Brandon G. Smaglo, Joy C. Tan, Hop S. Tran Cao, Benjamin L. Musher, and Nader N. Massarweh

cancer with D2 lymph node dissection: the ARTIST trial . J Clin Oncol 2012 ; 30 : 268 – 273 . 22184384 10.1200/JCO.2011.39.1953 6. Cunningham D , Allum WH , Stenning SP , . Perioperative chemotherapy versus surgery alone for resectable

Full access

Thomas W. Flaig, Philippe E. Spiess, Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Sam Chang, Tracy M. Downs, Jason A. Efstathiou, Terence Friedlander, Richard E. Greenberg, Khurshid A. Guru, Thomas Guzzo, Harry W. Herr, Jean Hoffman-Censits, Christopher Hoimes, Brant A. Inman, Masahito Jimbo, A. Karim Kader, Subodh M. Lele, Jeff Michalski, Jeffrey S. Montgomery, Lakshminarayanan Nandagopal, Lance C. Pagliaro, Sumanta K. Pal, Anthony Patterson, Elizabeth R. Plimack, Kamal S. Pohar, Mark A. Preston, Wade J. Sexton, Arlene O. Siefker-Radtke, Jonathan Tward, Jonathan L. Wright, Lisa A. Gurski, and Alyse Johnson-Chilla

surgery (biopsy or TURBT), and imaging studies. A modifier “p” would refer to pathologic staging based on cystectomy and lymph node dissection. Pathology and Staging The most commonly used staging system is the tumor, node, metastasis (TNM) staging system

Full access

Derek J. Erstad, Mariela Blum, Jeannelyn S. Estrella, Prajnan Das, Bruce D. Minsky, Jaffer A. Ajani, Paul F. Mansfield, Naruhiko Ikoma, and Brian D. Badgwell

; 11 : 439 – 449 . 20409751 10.1016/S1470-2045(10)70070-X 6. Seevaratnam R , Bocicariu A , Cardoso R , A meta-analysis of D1 versus D2 lymph node dissection . Gastric Cancer 2012 ; 15 ( Suppl 1 ): S60 – 69 . 10.1007/s10120

Full access

Fei Gao, Nan Li, YongMei Xu, and GuoWang Yang

prone to local recurrence and distant metastasis after surgery. 2 Multidisciplinary sequential therapy is applied in patients with stage IIIA NSCLC. Complete surgical resection of the primary lesion and mediastinal lymph node dissection are recommended

Full access

Jennifer L. Schwartz, Sandra L. Wong, Scott A. McLean, James A. Hayman, Christopher D. Lao, Jeffrey H. Kozlow, Kelly M. Malloy, Carol R. Bradford, Marcus L. Frohm, Douglas R. Fullen, Lori Lowe, and Christopher K. Bichakjian

angiolymphatic invasion, observation only is recommended at UM. For SLN-positive patients, lymph node dissection (LND) is the preferred treatment, although the optimal treatment for these patients is currently unknown. 31 LND is the most common initial treatment

Full access

C. Anthony Blau, Arturo B. Ramirez, Sibel Blau, Colin C. Pritchard, Michael O. Dorschner, Stephen C. Schmechel, Timothy J. Martins, Elisabeth M. Mahen, Kimberly A. Burton, Vitalina M. Komashko, Amie J. Radenbaugh, Katy Dougherty, Anju Thomas, Christopher P. Miller, James Annis, Jonathan R. Fromm, Chaozhong Song, Elizabeth Chang, Kellie Howard, Sharon Austin, Rodney A. Schmidt, Michael L. Linenberger, Pamela S. Becker, Francis M. Senecal, Brigham H. Mecham, Su-In Lee, Anup Madan, Roy Ronen, Janusz Dutkowski, Shelly Heimfeld, Brent L. Wood, Jackie L. Stilwell, Eric P. Kaldjian, David Haussler, and Jingchun Zhu

following month she underwent a right mastectomy with axillary lymph node dissection. Pathology revealed a 5.5-cm infiltrating carcinoma with lobular features, lymphovascular invasion with negative margins, and metastatic involvement in 20 of 25 lymph nodes

Full access

Andrea Maurichi, Rosalba Miceli, Roberto Patuzzo, Francesco Barretta, Gianfranco Gallino, Ilaria Mattavelli, Consuelo Barbieri, Andrea Leva, Umberto Cortinovis, Elena Tolomio, Milena Sant, Gianpiero Castelli, Leonardo Zichichi, Giovanni Pellacani, Ignazio Stanganelli, Marco Simonacci, Ausilia Manganoni, Corrado Del Forno, Gioachino Caresana, Catherine Harwood, Daniele Bergamaschi, Konstantinos Lasithiotakis, Dorothy Bennett, Vittoria Espeli, Cristina Mangas, Sandra Leoni Parvex, Barbara Valeri, Mara Cossa, Marta Barisella, Alessandro Pellegrinelli, Claudia Miranda, Andrea Anichini, Roberta Mortarini, Odysseas Zoras, and Mario Santinami

completion lymph node dissection (CLND) as additional therapy. Statistical Methods Clinicopathologic characteristics were recorded according to SNB (performed vs not performed) for the whole series of patients, according to SN status (positive vs negative) in

Full access

Thanh H. Dellinger, Amy A. Hakim, Stephen J. Lee, Mark T. Wakabayashi, Robert J. Morgan, and Ernest S. Han

JL . A randomized phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: a Gynecologic Oncology Group study . Gynecol Oncol 2008 ; 110 : 76 – 82 . 27. Van der Zee AG Oonk MH De Hullu JA